AwesomeCapital
Search This Blog
Thursday, February 13, 2020
Karyopharm Therapeutics EPS misses by $0.08, beats on revenue
Karyopharm Therapeutics (NASDAQ:
KPTI
): Q4 GAAP EPS of -$0.76
misses by $0.08
.
Revenue of $18.1M (+8950.0% Y/Y)
beats by $1.83M
.
Press Release
https://seekingalpha.com/news/3541610-karyopharm-therapeutics-eps-misses-0_08-beats-on-revenue
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.